Squarepoint
GMDA

Squarepoint’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Squarepoint’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-50,000
Closed -$51.5K – 4631
2023
Q3 		$51.5K Buy
+50,000
New +$63.9K ﹤0.01% 3632

Other funds holding GMDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LIM
Leavell Investment Management Mobile, Alabama $2.74B AUM 26.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Squarepoint's GMDA Position: Q1 2024 in Review

Squarepoint sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q1 2024, closing a stake of 542,741 shares — an estimated $224K sold.

Squarepoint first reported a position in GMDA in Q3 2020 and held it in 4 quarters. The position peaked at $304K in Q4 2020. 51 funds tracked by Wall St. Rank hold GMDA as of Q1 2024.

  • Squarepoint reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q1 2024 after selling out during the quarter.
  • Squarepoint sold 542,741 Gamida Cell Ltd. Ordinary Shares shares in Q1 2024, an estimated $224K.
  • Squarepoint first reported a position in Gamida Cell Ltd. Ordinary Shares in Q3 2020 and held it in 4 quarters.
  • Squarepoint's Gamida Cell Ltd. Ordinary Shares position peaked at $304K in Q4 2020.
  • 51 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q1 2024.

Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.